Rapid SDH vs StrokeViewer Perfusion

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by RapidAI (formerly iSchemaView)
VS
by NICo-Lab B.V.

AI Verdict

Tool A, Rapid SDH, is specifically designed for the rapid detection of subdural hematomas on non-contrast CT scans to aid in neurocritical care decisions for hemorrhagic conditions. In contrast, Tool B, StrokeViewer Perfusion, focuses on analyzing CT perfusion scans to provide quantitative brain tissue information for suspected ischemic stroke patients, though it also includes hemorrhage detection. While both are AI-powered neuroimaging tools for acute care, their primary target conditions and required imaging modalities make them adjacent rather than direct competitors.

Choose Rapid SDH if…

Choose Rapid SDH if your primary need is extremely rapid detection and notification of suspected acute or chronic subdural hematomas from non-contrast CT scans. This tool is ideal for emergency departments and neurocritical care units where accelerating time-sensitive decisions for potential neurosurgical intervention or patient transfer is critical, delivering alerts in under a minute.

View Rapid SDH →

Choose StrokeViewer Perfusion if…

Choose StrokeViewer Perfusion if your clinical workflow demands comprehensive quantitative analysis of CT perfusion scans for suspected ischemic stroke patients. This tool is best suited for stroke centers needing detailed insights into core infarct, penumbra volumes, and collateral circulation to guide complex thrombectomy decisions and optimize treatment strategies.

View StrokeViewer Perfusion →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rapid SDH StrokeViewer Perfusion
Pricing Contact vendor Contact for pricing
Deployment Cloud-based, On-premise Cloud-based; can be installed as a Docker container on standard computers or virtual platforms.
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

StrokeViewer Perfusion

StrokeViewer Perfusion emphasizes an 'easy-to-use' interface and is described as 'cloud-native and hardware-free stroke technology with weekly updates,' suggesting a smooth user experience and continuous improvement. It also offers a certified DICOM viewer for diagnostic use on mobile devices, enhancing accessibility for clinicians. While Rapid SDH focuses on rapid notifications (under one minute) and integration with existing systems, StrokeViewer's broader emphasis on user experience and mobile diagnostic capabilities gives it an edge.

Clinical Value

StrokeViewer Perfusion

StrokeViewer Perfusion provides a comprehensive suite of quantitative analyses for ischemic stroke, including perfusion maps, core and penumbra volume quantification, Large Vessel Occlusion (LVO) detection, hemorrhage detection, collateral circulation assessment, and ASPECTS scoring. This detailed output directly aids in complex treatment decisions and has been shown to reduce undetected LVOs and door-to-groin puncture time. While Rapid SDH offers high accuracy for SDH detection, StrokeViewer's broader and more granular clinical insights for stroke management provide greater overall clinical utility.

Pricing & Value

StrokeViewer Perfusion

StrokeViewer Perfusion provides some transparency by indicating a subscription-based pricing model tied to patient volume (categorized as Small/Medium/Large based on the number of stroke patients). This offers a clearer understanding of its value proposition, even without specific public costs. Rapid SDH only states 'Contact vendor' for pricing, offering no public details on its pricing structure.

Enterprise Readiness

Rapid SDH

Rapid SDH explicitly supports both cloud-based and on-premise deployment, which is often a critical requirement for larger enterprise healthcare systems. Furthermore, it is part of a 'comprehensive hemorrhagic and trauma care AI solution,' indicating a broader platform strategy for enterprise adoption across various trauma conditions. While StrokeViewer is FDA-cleared, HIPAA compliant, and offers flexible Docker container deployment, Rapid SDH's explicit on-premise option and integrated solution suite suggest a more robust offering for complex enterprise environments.

Innovation

StrokeViewer Perfusion

StrokeViewer Perfusion demonstrates broader innovation through its highly detailed, quantitative, and transparent analysis for ischemic stroke, encompassing core/penumbra quantification, LVO, hemorrhage, and collateral assessment. It also highlights a commitment to continuous innovation based on user feedback and offers 'Transparent AI' by displaying underlying data and processing steps. While Rapid SDH is innovative in its speed and high accuracy for SDH detection, StrokeViewer's comprehensive quantitative approach and transparency features represent a more expansive innovative offering.

Support & Docs

Rapid SDH

Rapid SDH explicitly offers 24/7 customer support via email and phone, with dedicated regional contact numbers, along with professional education and implementation support. StrokeViewer mentions email support and an interactive training module, but does not specify 24/7 availability or a range of direct phone contacts for support. Rapid SDH's clearly outlined and readily available support options indicate a more robust support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rapid SDH StrokeViewer Perfusion
Product Name Rapid SDH StrokeViewer Perfusion
Company RapidAI (formerly iSchemaView) NICo-Lab B.V.
Description FDA-cleared AI module that rapidly detects suspected acute and chronic subdural hematomas on CT scans, delivering notifications in under a minute to accelerate neurocritical care decisions. AI-powered image processing software that analyzes CT perfusion scans to provide quantitative brain tissue information for suspected ischemic stroke patients, aiding in rapid diagnosis and treatment decisions.
Key Features AI-powered detection of suspected hemispheric acute and chronic subdural hematoma (SDH); Notifications to clinicians in one minute or less; High positive predictive value (PPV) of 99% (93% sensitivity, 99% specificity) for SDHs >1ml; Integration with Rapid mobile app, PACS, and email for notifications; Part of a comprehensive hemorrhagic and trauma care AI solution (with Rapid ICH and Rapid Hyperdensity); Analyzes non-contrast CT scans; Aids in streamlining decision-making and expediting patient care; Supports identification of treatment eligibility AI-powered CT Perfusion analysis; Quantitative perfusion maps (TMax, CBF, CBV); Lesion map for core and penumbra volume quantification; Large Vessel Occlusion (LVO) detection; Hemorrhage detection and quantification; Collateral circulation assessment; ASPECTS scoring; Mobile notifications for critical findings
Target Condition Suspected acute and chronic subdural hematomas (SDH) Suspected ischemic stroke
Imaging Modality Non-contrast CT scans CT perfusion scans
Specialties Emergency Medicine, Neurosurgery, Radiology Emergency Medicine, Neurology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Rapid SDH and StrokeViewer Perfusion.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rapid SDH (Tool A) is an AI module designed for the rapid detection of suspected acute and chronic subdural hematomas on non-contrast CT scans, aiming to accelerate neurocritical care decisions. StrokeViewer Perfusion (Tool B) is an AI-powered image processing software that analyzes CT perfusion scans to provide quantitative brain tissue information for suspected ischemic stroke patients, aiding in rapid diagnosis and treatment decisions.
Rapid SDH (Tool A) analyzes non-contrast CT scans for the detection of suspected hemispheric acute and chronic subdural hematomas. StrokeViewer Perfusion (Tool B) analyzes CT perfusion scans to provide quantitative brain tissue information for suspected ischemic stroke patients.
Rapid SDH (Tool A) delivers notifications for suspected subdural hematomas in under a minute. StrokeViewer Perfusion (Tool B) also aims for rapid diagnosis and treatment decisions, with mobile notifications for critical findings.
Rapid SDH (Tool A) detects suspected hemispheric acute and chronic subdural hematomas with a positive predictive value (PPV) of 99% (93% sensitivity, 99% specificity) for SDHs >1ml. StrokeViewer Perfusion (Tool B) provides quantitative perfusion maps (TMax, CBF, CBV), lesion maps for core and penumbra volume quantification, Large Vessel Occlusion (LVO) detection, hemorrhage detection, collateral circulation assessment, and ASPECTS scoring.
Rapid SDH (Tool A) is explicitly stated to be part of a comprehensive hemorrhagic and trauma care AI solution, alongside Rapid ICH and Rapid Hyperdensity. The provided information for StrokeViewer Perfusion (Tool B) focuses on its specific capabilities for ischemic stroke.
AI Tool Finder
AI-powered search. Results may not be comprehensive.